Features Partner Sites Information LinkXpress
Sign In

Genetic Mutations Linked to Autism Subtype

By Labmedica International staff writers
Posted on 17 Jul 2014
Print article
Illumina HiSeq 2500 sequencing system
The HiSeq 2500 sequencing system (Photo courtesy of Illumina)
Autism spectrum disorder (ASD) is a heterogeneous disorder with significant genotypic and phenotypic complexity, and definitive cause of autism to a genetic mutation has been revealed.

Previously identified genetic events like Fragile X, which account for a greater number of autism cases, are associated with other impairments, such as intellectual disability, more than autism, while some will have autism marked by gastrointestinal disorders, a larger head and wide set eyes.

In collaboration involving 13 institutions around the world, a study was made of 6,176 children with autism spectrum disorder. Led by scientists from the University of Washington (Seattle, WA, USA) they collected blood samples and genomic DNA was isolated. Molecular inversion probes (MIP) were performed using HiSeq-based sequencing (Illumina; San Diego, CA, USA) and analyzed. They utilized a custom 8 × 60K comparative genomic hybridization (CGH) array (Agilent, Santa Clara, CA, USA) with 150 base pair (bp) probe spacing across the gene body of a specific gene and predicted neighboring regulatory elements.

The scientists found that 15 of 6,176 children with ASD had a mutation in the gene encoding for chromodomain-helicase-DNA-binding protein 8 (CHD8) and all these cases had similar characteristics in appearance and issues with sleep disturbance and gastrointestinal problems. They identified a total of 15 independent mutations and no truncating events were identified in 8,792 controls, including 2,289 unaffected siblings. In addition to a high likelihood of an ASD diagnosis among patients bearing CHD8 mutations, characteristics enriched in this group included macrocephaly, distinct faces, and gastrointestinal complaints.

The most commonly researched genetic events associated with autism are chromosomal re-arrangements, called "copy number variations," in which a chunk of chromosome is copied or deleted, but no one rearrangement affects more than 1% of all autism cases. While these copy number events are associated with autism, they do not have a definitive link, or as they say among scientists, a “strong penetrance.”

Raphael Bernier, PhD, a professor of psychiatry and the lead author of the study said, “We finally got a clear cut case of an autism specific gene. This will be a game changer in the way scientists are studying autism. Although less than half a percent of all kids will have this kind of autism related to the CHD8 mutation, there are lots of implications from this study.” The study was published on July 3, 2014, in the journal Cell.

Related Links:

University of Washington 

Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every 2 weeks containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
Click here to Register




view channel
Image: Sysmex XE-5000 automated hematology analyzer (Photo courtesy of Sysmex Corporation).

Hematology Analyzers Contribute to Differentiating Febrile Illnesses

Distinguishing Dengue virus infection from other febrile thrombocytopenic illnesses such as leptospirosis or enteric fever is important but difficult, due to the unavailability of reliable diagnostic tests.... Read more

Industry News

view channel

Growth Continues in Infectious Disease Diagnostics

Global testing for infectious diseases has reached USD 16.8 Billion and the segment continues to expand from demand, growing infrastructure in emerging nations, and intense competition, according to a new healthcare market study. The findings were presented in the latest Kalorama Information (New York, NY, USA) report... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.